BioScout is a source-grounded biotech intelligence workspace. This public repository is a minimal example dataset, not the full private development workspace.
The public example company is Revolution Medicines. The records are structured so that report prose can trace back to source IDs, evidence quotes, confidence levels, review status, and open questions.
companies/revolution_medicines/profile.yaml: company profile and summary claim IDscompanies/revolution_medicines/seed_sources.yaml: public source metadatacompanies/revolution_medicines/claims.yaml: source-linked claim ledgercompanies/revolution_medicines/open_questions.yaml: unresolved diligence questionscompanies/revolution_medicines/report_config.yaml: report page configurationconfig/companies/revolution_medicines.yaml: company config entry
Generated docs, source code, local data ledgers, and private company examples are intentionally not included in this public repository.
BioScout treats biomedical, clinical, funding, patent, and investment-adjacent claims as uncertain unless they are directly sourced. Company disclosures are preserved as company disclosures, not independent validation.
High-risk facts such as clinical status, regulatory designations, patent ownership, license status, funding terms, efficacy, and safety should remain caveated unless direct source support is available.
The Revolution Medicines seed data uses public source metadata and compact evidence excerpts to demonstrate the data shape:
- source records have stable
source_idvalues - claims reference one or more source IDs
- claims include evidence text snippets for traceability
- high-risk claims carry higher risk levels and review notes
- open questions make uncertainty explicit
This repository is intended as a public, reviewable example of the data model and source-grounded review style.